Elliptic Laboratories ASA
F:EIP
Elliptic Laboratories ASA
F:EIP
Price:
0.2245
EUR
-1.1%
Market Closed
Market Cap:
€23.5m
Balance Sheet
Balance Sheet Decomposition
Elliptic Laboratories ASA
Elliptic Laboratories ASA
Balance Sheet Decomposition is not available for
Elliptic Laboratories ASA
Elliptic Laboratories ASA
Balance Sheet
Elliptic Laboratories ASA
Elliptic Laboratories ASA
Currency: NOK
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
35
|
14
|
33
|
99
|
217
|
176
|
116
|
74
|
43
|
|
| Cash Equivalents |
35
|
14
|
33
|
99
|
217
|
176
|
116
|
74
|
43
|
|
| Total Receivables |
10
|
20
|
21
|
18
|
47
|
47
|
67
|
118
|
89
|
|
| Accounts Receivables |
3
|
15
|
14
|
0
|
29
|
40
|
61
|
111
|
81
|
|
| Other Receivables |
6
|
6
|
7
|
18
|
18
|
7
|
6
|
7
|
8
|
|
| Other Current Assets |
3
|
3
|
2
|
5
|
1
|
2
|
6
|
4
|
0
|
|
| Total Current Assets |
47
|
37
|
56
|
122
|
265
|
226
|
186
|
195
|
132
|
|
| PP&E Net |
0
|
0
|
7
|
5
|
3
|
2
|
20
|
17
|
12
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
20
|
17
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
7
|
0
|
|
| Intangible Assets |
3
|
10
|
17
|
28
|
37
|
48
|
56
|
66
|
71
|
|
| Note Receivable |
1
|
2
|
4
|
4
|
5
|
5
|
9
|
7
|
6
|
|
| Other Long-Term Assets |
47
|
53
|
56
|
60
|
63
|
69
|
78
|
75
|
0
|
|
| Total Assets |
98
N/A
|
102
+4%
|
139
+36%
|
219
+57%
|
371
+70%
|
349
-6%
|
348
0%
|
361
+4%
|
222
-39%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
3
|
1
|
1
|
3
|
2
|
4
|
1
|
2
|
|
| Accrued Liabilities |
6
|
7
|
8
|
6
|
8
|
9
|
13
|
15
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
43
|
31
|
6
|
7
|
6
|
8
|
9
|
5
|
|
| Other Current Liabilities |
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
|
| Total Current Liabilities |
13
|
55
|
40
|
14
|
18
|
17
|
25
|
25
|
24
|
|
| Long-Term Debt |
14
|
0
|
19
|
17
|
11
|
7
|
18
|
11
|
8
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
27
N/A
|
55
+106%
|
59
+8%
|
31
-48%
|
29
-7%
|
24
-17%
|
43
+81%
|
36
-17%
|
32
-11%
|
|
| Equity | ||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Additional Paid In Capital |
2
|
6
|
71
|
175
|
343
|
346
|
36
|
360
|
0
|
|
| Other Equity |
69
|
40
|
9
|
13
|
1
|
21
|
269
|
36
|
189
|
|
| Total Equity |
72
N/A
|
47
-34%
|
80
+69%
|
188
+135%
|
343
+82%
|
326
-5%
|
305
-6%
|
325
+7%
|
190
-42%
|
|
| Total Liabilities & Equity |
98
N/A
|
102
+4%
|
139
+36%
|
219
+57%
|
371
+70%
|
349
-6%
|
348
0%
|
361
+4%
|
222
-39%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
86
|
86
|
88
|
96
|
104
|
104
|
105
|
105
|
105
|
|
Switch to:
Switch to:
See Also
Discover More
